摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基-4-甲氧基-5-硝基-6-氯嘧啶 | 60331-15-9

中文名称
2-甲基-4-甲氧基-5-硝基-6-氯嘧啶
中文别名
——
英文名称
2-methyl-4-methoxy-5-nitro-6-chloro-pyrimidine
英文别名
2-Methyl-4-methoxy-5-nitro-6-chloropyrimidine;4-chloro-6-methoxy-2-methyl-5-nitropyrimidine;4-chloro-6-methoxy-2-methyl-5-nitro-pyrimidine;4-Chlor-6-methoxy-2-methyl-5-nitro-pyrimidin;6-chloro-4-methoxy-2-methyl-5-nitro-pyrimidine
2-甲基-4-甲氧基-5-硝基-6-氯嘧啶化学式
CAS
60331-15-9
化学式
C6H6ClN3O3
mdl
——
分子量
203.585
InChiKey
XENBELIGWDKZOP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    80.8
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:49f22965d5765caa90240905b07e6b61
查看

上下游信息

反应信息

点击查看最新优质反应信息

文献信息

  • 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives
    申请人:Hoffmann-La Roche Inc.
    公开号:US06218385B1
    公开(公告)日:2001-04-17
    The present invention is concerned with 1,2,4,5-tetrahydro-benzo[d]azepin derivatives as well as with their pharmaceutically acceptable salts in their racemic and optically active form, which compounds are antagonists at metabotropic glutamate receptors and therefore useful for the treatment of diseases related to these receptors.
    本发明涉及1,2,4,5-四氢苯并[d]氮杂环己烷衍生物,以及它们的药用盐,无论是它们的外消旋形式还是光学活性形式,这些化合物是代谢型谷氨酸受体拮抗剂,因此对于治疗与这些受体相关的疾病是有用的。
  • 4-(N,N-Dialkylthiocarbamoylthio)-5-nitropyrimidines as new potential nitric oxide donors
    作者:O. B. Ryabova、E. Yu. Khmel’nitskaya、V. A. Makarov、L. M. Alekseeva、N. B. Grigor’ev、V. G. Granik
    DOI:10.1007/s11172-006-0203-5
    日期:2005.12
    On heating at pH 6.86, 4-(N,N-dialkylthiocarbamoylthio)-5-nitropyrimidines are transformed into dithiolopyrimidines, which are either oxidized to bis(4-dialkylthiocarbamoylpyrimidin-5-yl) disulfides or converted into 4,6-diamino-5-nitropyrimidine derivatives with carbon disulfide elimination. The direction of the reaction is determined by the nature of a substituent in position 2 of pyrimidine and the bulk of the thiocarbamate substituent. Mechanistic schemes for these processes were proposed.
    加热至pH 6.86时,4-(N,N-二烷基硫代氨基甲酰基硫)-5-硝基嘧啶转化为二硫嘧啶,这些二硫嘧啶要么被氧化为双(4-二烷基硫代氨基甲酰基嘧啶-5-基)二硫化物,要么转化为4,6-二氨基-5-硝基嘧啶衍生物,并伴随有二硫化碳的消除。反应的方向由嘧啶2位取代基的性质和硫代氨基甲酸酯取代基的体积决定。为这些过程提出了机理方案。
  • Condensed Heteroaromatic Ring Systems. XXI. Synthesis of Pyrrolo(2,3-d)pyrimidines and Pyrrolo(3,2-d)pyrimidines.
    作者:Takao SAKAMOTO、Chisato SATOH、Yoshinori KONDO、Hiroshi YAMANAKA
    DOI:10.1248/cpb.41.81
    日期:——
    Pyrrolo[2, 3-d]pyrimidines and pyrrolo[3, 2-d]pyrimidines were synthesized in high yields by the palladiumcatalyzed reaction of 4-acetylamino-5-bromopyrimidines and 5-acetylamino-4-iodopyrimidines with (Z)-1-ethoxy-2-(tributylstannyl)ethene followed by cyclization under acidic conditions.
    在钯催化下,4-乙酰氨基-5-溴嘧啶和 5-乙酰氨基-4-碘嘧啶与(Z)-1-乙氧基-2-(三丁基锡)乙烯反应,然后在酸性条件下环化,高产率合成了吡咯并[2,3-d]嘧啶和吡咯并[3,2-d]嘧啶。
  • mGluR antagonists and a method for their synthesis
    申请人:Hoffmann-La Roche Inc.
    公开号:US06369222B1
    公开(公告)日:2002-04-09
    The invention relates to nitro- and cyano-1,2,4,5-tetrahydro-heterocycloazepinyl pyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to medicaments containing such compounds and a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control or prevention of acute and/or chronic neurological disorders.
    本发明涉及硝基和氰基1,2,4,5-四氢杂环辛基嘧啶衍生物及其药学上可接受的盐。本发明还涉及含有这种化合物的药物以及制备这种化合物的过程。本发明的化合物是I组mGluR拮抗剂,因此对于控制或预防急性和/或慢性神经系统疾病非常有用。
  • Novel mGluR antagonists and a method for their synthesis
    申请人:——
    公开号:US20020045635A1
    公开(公告)日:2002-04-18
    The invention relates to nitro- and cyano-1,2,4,5-tetrahydro-heterocycloazepinyl pyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to medicaments containing such compounds and a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control or prevention of acute and/or chronic neurological disorders.
    本发明涉及硝基和氰基1,2,4,5-四氢杂环庚啶基嘧啶衍生物及其药学上可接受的盐。本发明还涉及含有这种化合物的药物以及制备这种化合物的方法。本发明的化合物是I群mGluR拮抗剂,因此对于控制或预防急性和/或慢性神经系统疾病是有用的。
查看更多